60 Degrees Pharmaceuticals (SXTP) Interest Coverage Ratio (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Interest Coverage Ratio of 283.1 for Q1 2026, down 439.66% year-over-year from 83.35 in Q1 2025, and up 40.16% quarter-over-quarter from 473.07 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Interest Coverage Ratio for 5 consecutive years, with 283.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 439.66% year-over-year to 283.1; the TTM figure through Mar 2026 stood at 1073.33 (down 280.2% YoY), while the FY2025 annual figure was 0.95, up 42.05% from the prior year.
- Interest Coverage Ratio grew to 283.1 in Q1 2026 per SXTP's latest filing, from 473.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 8.24 in Q4 2022 and bottomed at 905.04 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 207.2 across 5 years, with a median of 52.46 in 2025.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio plunged 173888.79% — and 2025, when it soared 92.82%.
- 60 Degrees Pharmaceuticals' Interest Coverage Ratio stood at 8.24 in 2022, then tumbled by 3833.39% to 307.8 in 2023, then plunged by 194.03% to 905.04 in 2024, then soared by 47.73% to 473.07 in 2025, then jumped by 40.16% to 283.1 in 2026.
- Business Quant data shows SXTP's Interest Coverage Ratio at 283.1 in Q1 2026, 473.07 in Q4 2025, and 60.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | -1,618.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -283.10 |
| Dec 31, 2025 | -473.07 |
| Sep 30, 2025 | -60.51 |
| Jun 30, 2025 | -44.06 |
| Mar 31, 2025 | -52.46 |
| Dec 31, 2024 | -905.04 |
| Sep 30, 2024 | -302.24 |
| Jun 30, 2024 | -613.38 |
| Mar 31, 2024 | -24.28 |
| Sep 30, 2023 | -307.80 |
| Jun 30, 2023 | -25.13 |
| Mar 31, 2023 | -0.83 |
| Dec 31, 2022 | 8.24 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -24.19 |